Oncogenic BRAF Mutation With CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas

Cancer Research - United States
doi 10.1158/0008-5472.can-09-1851
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Distinct Subset of Atypical Spitz Tumors Is Characterized by BRAF Mutation and Loss of BAP1 Expression

American Journal of Surgical Pathology
AnatomyForensic MedicinePathologySurgery
2012English

Treating Malignant Melanoma When a Rare BRAF V600M Mutation Is Present: Case Report and Literature Review

Romanian Journal of Internal Medicine
Medicine
2018English

CDKN2A and CDK4 Mutation Analysis in Italian Melanoma-Prone Families: Functional Characterization of a Novel CDKN2A Germ Line Mutation

British Journal of Cancer
Cancer ResearchOncology
2001English

Constitutional Mutation in CDKN2A Is Associated With Long Term Survivorship in Multiple Myeloma: A Case Report

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

CDKN2A Germline Mutations in Individuals With Cutaneous Malignant Melanoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2007English

Oncogenic AKAP9-BRAF Fusion Is a Novel Mechanism of MAPK Pathway Activation in Thyroid Cancer

Journal of Clinical Investigation
Medicine
2005English

PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

Hyperplastic Polyposis Syndrome Identifi Ed With a BRAF Mutation

Gut and Liver
HepatologyGastroenterology
2012English

INPP4B Is Upregulated and Functions as an Oncogenic Driver Through SGK3 in a Subset of Melanomas

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy